0001567619-18-004313.txt : 20181018
0001567619-18-004313.hdr.sgml : 20181018
20181018172248
ACCESSION NUMBER: 0001567619-18-004313
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180515
FILED AS OF DATE: 20181018
DATE AS OF CHANGE: 20181018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moscato Robert Jr.
CENTRAL INDEX KEY: 0001723420
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 181128938
MAIL ADDRESS:
STREET 1: 400 PRATT STREET
STREET 2: SUITE 606
CITY: BALTIMORE
STATE: MD
ZIP: 21202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LRS International, LLC
CENTRAL INDEX KEY: 0001756192
STATE OF INCORPORATION: NC
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 181128939
BUSINESS ADDRESS:
STREET 1: 9116 WINGED THISTLE COURT
CITY: RALEIGH
STATE: NC
ZIP: 27617
BUSINESS PHONE: 919-345-5544
MAIL ADDRESS:
STREET 1: 9116 WINGED THISTLE COURT
CITY: RALEIGH
STATE: NC
ZIP: 27617
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerecor Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 E. PRATT ST.
STREET 2: SUITE 606
CITY: BALTIMORE
STATE: MD
ZIP: 21202
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 400 E. PRATT ST.
STREET 2: SUITE 606
CITY: BALTIMORE
STATE: MD
ZIP: 21202
4
1
doc1.xml
FORM 4
X0306
4
2018-05-15
1
0001534120
Cerecor Inc.
CERC
0001723420
Moscato Robert Jr.
9116 WINGED THISTLE COURT
RALEIGH
NC
27617
0
0
1
0
0001756192
LRS International, LLC
9116 WINGED THISTLE COURT
RALEIGH
NC
27617
0
0
1
0
On September 24, 2018, the Issuer entered into and subsequently consummated the transactions contemplated by an Agreement and Plan of Merger among the Issuer, ITX Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Issuer, Second ITX Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer, Ichorion Therapeutics, Inc., a Delaware Corporation ("Ichorion"), and a Holders' Representative, providing for the merger of Ichorion with the Issuer, with Ichorion surviving as a wholly owned subsidiary of the Issuer. The consideration for the Merger at closing consisted of 5,798,735 shares of the Issuer's Common Stock, par value $0.001 per share (the "Merger Shares"), as adjusted for Estimated Working Capital. As a result of the Issuer's issuance of the Merger Shares, the Reporting Persons' beneficial ownership of the Issuer is now below 10%, and the Reporting Persons are no longer subject to Section 16.
/s/ Robert Moscato, Jr
2018-10-17
/s/ LRS International, LLC, by Robert Moscato, Jr.
2018-10-17